“Can you comment on the limitations of IM versus Sub-Q?” Chong-Hui Gu answers an audience member’s question from last week’s Formulation Forum webinar in this clip from the Q&A session. While we cannot share the recording of this webinar, please enjoy this clip. Stay tuned for more clips in the coming days! 📅 Don’t miss our next webinar on August 21 at 2pm EDT. Register today at: https://lnkd.in/d3s2X3kg #CrystalPharmatech #FormulationForum #PharmaceuticalScience #CMC #Biotech #DrugDevelopment #Formulation #Pharma #Research #Technology #API #CRO #CDMO
Crystal Pharmatech’s Post
More Relevant Posts
-
The first episode of Crystal Pharmatech Formulation Forum - "Overcoming Poor Solubility and Dissolution of Insoluble Molecules" is going to be streamed on April 17 at 2 PM EDT. For Registration: https://lnkd.in/eZTXvYzA #drugdevelopment #formulationdevelopment #researchanddevelopment #cdmo
📢 Register for April 17th at 2pm: Sudhakar Garad, Ph.D. from Novartis joins us for the first episode of the Crystal Pharmatech Formulation Forum. Live attendance is the only opportunity to view this webinar – we cannot provide a recording. 📅 Register and view details: https://lnkd.in/eucG6e-v #CrystalPharmatech #FormulationForum #PharmaceuticalScience #CMC #Biotech #DrugDevelopemnt #Formulation #Pharma #Research #Technology #API #CRO #CDMO
Formulation Forum: Episode 1
To view or add a comment, sign in
-
It's almost here!!! Looking forward to seeing you at this educational event! The first episode of Crystal Pharmatech Formulation Forum - "Overcoming Poor Solubility and Dissolution of Insoluble Molecules" is going to be streamed on April 17 at 2 PM EDT. For Registration: https://lnkd.in/eZTXvYzA #drugdevelopment #formulationdevelopment #drugproduct #researchanddevelopment
📢 Register for April 17th at 2pm: Sudhakar Garad, Ph.D. from Novartis joins us for the first episode of the Crystal Pharmatech Formulation Forum. Live attendance is the only opportunity to view this webinar – we cannot provide a recording. 📅 Register and view details: https://lnkd.in/eucG6e-v #CrystalPharmatech #FormulationForum #PharmaceuticalScience #CMC #Biotech #DrugDevelopemnt #Formulation #Pharma #Research #Technology #API #CRO #CDMO
Formulation Forum: Episode 1
To view or add a comment, sign in
-
Trial AMPlify launches a clinical study website for the Cystic Fibrosis Foundation to help develop new treatments for people with CF, including people who do not take CFTR modulators. #CF #clinicaltrials #pharma #biotech #lifescience #drugdiscovery #patientrecruitment
To view or add a comment, sign in
-
-
Overcoming formulation challenges through an advanced understanding of your molecule. Join Robert Wenslow, Ph.D. as he outlines the first compound of this CDMO Case Study Series. These videos will dive into various examples where Crystal Pharmatech’s 3-step, first-time-right approach helped ensure a successful formulation for drug innovators. 🔹 Molecule 🔹 Material 🔹 Medicine Subscribe to Crystal Pharmatech on YouTube for more content: https://lnkd.in/eaCd5t6P Crystal Formulation Services, a member of Crystal Pharmatech #CrystalPharmatech #FormulationForum #PharmaceuticalScience #CMC #Biotech #DrugDevelopemnt #Formulation #Pharma #Research #Technology #API #CRO #CDMO
2024 CDMO Case Study Series - Compound 1
To view or add a comment, sign in
-
Insights in ASD: Join us on Wednesday for another webinar in the Crystal Pharmatech Formulation Forum. Na Li, Ph.D. will detail topics in ASD formulations, including: 🔹 Amorphous drug nanoparticles for increased bioavailability 🔹 Extent of permeability enhancement from drug nanoparticles 🔹 Developing stable amorphous formulations 📅 Register to attend May 8th at 2pm EDT: https://lnkd.in/eWHvjyE8 Please note, we cannot share the recording. Live attendance will be the only opportunity to view this presentation. #CrystalPharmatech #FormulationForum #PharmaceuticalScience #CMC #Biotech #DrugDevelopemnt #Formulation #Pharma #Research #Technology #API #CRO #CDMO
To view or add a comment, sign in
-
Explore the Agenda for Our December Bioequivalence Training Get insights into general biostudy requirements, in-depth discussions on similarity, comparability, and correlation, and tackle validation challenges. Check out the full agenda for our upcoming bioequivalence training in December to see if it aligns with your goals. Register via the link in the comments! #drugdevelopment #pharma #bioequivalence #IVIVC #onlinetraining
To view or add a comment, sign in
-
-
In the process of research and development of small molecule drug molecular building blocks, we have accumulated a lot of technical experience and achieved a wide recognition from our customers through fast delivery and high-quality services, laying a solid foundation for the company further to provide chemical CRO services and chemical CDMO services. #CRO #CDMO #smallmolecules #customsynthesis #buildingblocks #pharma #researchanddevelopment #smallmolecules #bellenchem #medicinalchemistry #drugdiscovery #FTE #Chemistryservices #processdevelopment #QC
To view or add a comment, sign in
-
-
It's crucial to clearly understand the molecule and it's solid-state properties to guide the appropriate formulation development pathway for First-in-Human. Correct formulation development strategy minimizes the requirement for multiple prototype formulations, PK bridging studies and can accelerate the drug development in the fastest, cost effective and the most material-sparing manner. #DrugDevelopment #CMC #Formulation #FormulationDevelopment #ResearchandDevelopment #SolidState #API #DrugSubstance #DrugProduct #Manufacturing #CTM #CRO #CDMO
Formulation challenges can be addressed by gaining an advanced understanding of your molecule. Join Robert Wenslow, Ph.D. as he continues the CDMO Case Study Series. These videos will dive into various examples where Crystal Pharmatech’s 3-step, first-time-right approach helped ensure a successful formulation for drug innovators. 🔹 Molecule 🔹 Material 🔹 Medicine Subscribe to Crystal Pharmatech on YouTube for more content: https://lnkd.in/eHYFwCwG Crystal Formulation Services, a member of Crystal Pharmatech #CrystalPharmatech #FormulationForum #PharmaceuticalScience #CMC #Biotech #DrugDevelopemnt #Formulation #Pharma #Research #Technology #API #CRO #CDMO
2024 CDMO Case Study Series - Compound 2
To view or add a comment, sign in
-
Can MICRO-TAG cell target engagement system be applied to transcription factors (TFs)? #MICROTAG #PrecisionTherapeutics #DrugDiscovery #CellTargetEngagement #DrugTargeting #ChallengingTarget #DrugTarget #BiotechInnovation #TherapeuticDiscovery #BiomedicalInnovation #CellarisBio #DEL #Biotech #Pharma #BiotechAdvancements #PrecisionMedicine #BiotechInnovation
To view or add a comment, sign in
-
Formulation challenges can be addressed by gaining an advanced understanding of your molecule. Join Robert Wenslow, Ph.D. as he continues the CDMO Case Study Series. These videos will dive into various examples where Crystal Pharmatech’s 3-step, first-time-right approach helped ensure a successful formulation for drug innovators. 🔹 Molecule 🔹 Material 🔹 Medicine Subscribe to Crystal Pharmatech on YouTube for more content: https://lnkd.in/eHYFwCwG Crystal Formulation Services, a member of Crystal Pharmatech #CrystalPharmatech #FormulationForum #PharmaceuticalScience #CMC #Biotech #DrugDevelopemnt #Formulation #Pharma #Research #Technology #API #CRO #CDMO
2024 CDMO Case Study Series - Compound 2
To view or add a comment, sign in
More from this author
-
Crystal Pharmatech Recognized as "Best Partner" by Allorion Therapeutics for Excellent Services
Crystal Pharmatech 1y -
Crystal Formulation Services’ GMP Manufacturing Facility Successfully Passes the Remote Audit by US Client
Crystal Pharmatech 1y -
Crystal Pharmatech’s CDMO Business Unit Received China Drug Product Manufacturing License, Achieving the Important Milestone in Formulation Capability
Crystal Pharmatech 2y